Home  »  Business   »  Kiromic BioPharma Inc. (NASDAQ:KRBP) Drops -31.71 ...

Kiromic BioPharma Inc. (NASDAQ:KRBP) Drops -31.71 Percent In A Week: What Motivates The Stock?

In recent trading session, Kiromic BioPharma Inc. (NASDAQ:KRBP) saw 12.5 million shares changing hands at last check today with its beta currently measuring 0. Company’s recent per share price level of $0.52 trading at $0.26 or 104.65% at last check today assigns it a market valuation of $4.16M. That most recent trading price of KRBP’s stock is at a discount of -600.0% from its 52-week high price of $3.64 and is indicating a premium of 55.77% from its 52-week low price of $0.23. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 75640.0 shares which gives us an average trading volume of 636.39K if we extend that period to 3-months.

Kiromic BioPharma Inc. (NASDAQ:KRBP) trade information

Upright in the green today for gaining 104.65%, in the last five days KRBP remained trading in the red while hitting it’s week-highest on Friday, 09/23/22 when the stock touched $0.52 price level, adding 20.0% to its value on the day. Kiromic BioPharma Inc.’s shares saw a change of -83.26% in year-to-date performance and have moved -31.71% in past 5-day. Kiromic BioPharma Inc. (NASDAQ:KRBP) showed a performance of -41.78% in past 30-days. Number of shares sold short was 0.38 million shares which calculate 0.34 days to cover the short interests.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Kiromic BioPharma Inc. (KRBP) estimates and forecasts

Statistics highlight that Kiromic BioPharma Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -71.29% of value to its shares in past 6 months, showing an annual growth rate of -46.26% while that of industry is 2.00. Apart from that, the company came lowering its revenue forecast for fiscal year 2022.

KRBP Dividends

Kiromic BioPharma Inc. is more likely to be releasing its next quarterly report between March 29 and April 04 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Kiromic BioPharma Inc. (NASDAQ:KRBP)’s Major holders

Insiders are in possession of 12.69% of company’s total shares while institution are holding 12.67 percent of that, with stock having share float percentage of 14.51%. Investors also watch the number of corporate investors in a company very closely, which is 12.67% institutions for Kiromic BioPharma Inc. that are currently holding shares of the company. Kepos Capital Lp is the top institutional holder at KRBP for having 0.77 million shares of worth $0.66 million. And as of Mar 30, 2022, it was holding 4.84% of the company’s outstanding shares.

The second largest institutional holder is Lynwood Capital Management Inc., which was holding about 0.3 million shares on Mar 30, 2022. The number of shares represents firm’s hold over 1.89% of outstanding shares, having a total worth of $0.26 million.

On the other hand, Vanguard Total Stock Market Index Fund and Fidelity NASDAQ Composite Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 30, 2022, the former fund manager was holding 0.28 million shares of worth $0.24 million or 1.78% of the total outstanding shares. The later fund manager was in possession of 36662.0 shares on May 30, 2022, making its stake of worth around $12698.0 in the company or a holder of 0.23% of company’s stock.

Leave a Comment

Your email address will not be published.

On Key

Related Posts